Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

NEW
AMEX:LCTX (USA)  
$ 1.06 -0.040 (-3.64%) 10:08 PM EST
At Loss
P/B:
4.42
Market Cap:
$ 268.08M
Enterprise V:
$ 218.43M
Volume:
948.94K
Avg Vol (2M):
1.54M
Trade In:
Volume:
948.94K
At Loss
Avg Vol (2M):
1.54M

Lineage Cell Therapeutics Inc (LCTX) Dividend

Lineage Cell Therapeutics Inc (LCTX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -12.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LCTX Dividend

Does Lineage Cell Therapeutics Inc (LCTX) pay a dividend?

Lineage Cell Therapeutics Inc (LCTX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Lineage Cell Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Lineage Cell Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -12.6% over the past 3 years.

What are dividend-paying alternatives to Lineage Cell Therapeutics Inc?

For dividend-paying alternatives in Lineage Cell Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.